Jonathon Mellor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jonathon Mellor has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Thomas Ward
UK Health Security Agency
12 shared publications- Maria L. Tang
UK Health Security Agency
10 shared publications - Thomas Ward
UK Health Security Agency
8 shared publications Rachel Christie
Affiliation Chief Data Officer Group, UK Health Security Agency, London, United Kingdom
7 shared publicationsRobert S. Paton
UK Health Security Agency
6 shared publicationsChristopher E. Overton
Infectious Disease Modelling Team, Modelling Division, Chief Data Officer Group, UK Health Security Agency, London, UK
5 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 5 (10) , e0001759
Recommendations for the analysis of leading indicators in epidemic surveillance
Leading indicator analyses, a type of time series analysis, are frequently used to assess how epidemic surveillance signals relate to one another. Strong leading indicators can drive early, and better decisions in public health systems. We conducted a narrative review of leading indicator studies and evaluated methodological limitations in their reporting and analysis, which we used to generate recommendations in retrospective surveillance analyses. Achievable recommendations are provided based on the reporting and analysis components of real-time epidemic time series analysis. We provide contextual examples from the literature of previous studies demonstrating good practice and highlighting areas for improvement. We present a checklist and workflow that emphases real-time constraints. These recommendations include causal mechanism reporting, sample coverage and bias, reporting delays and data revisions, multiple event measurement, spatio-temporal granularly, time varying relationships, smoothing, transformations, uncertainty, and predictive utility. By following these good practices, analysts can improve research on leading indicators to make analyses more directly actionable for public health decision makers. This work builds on the existing methodology literature by giving a broader framework for overall good practices.
- 5 October 2026
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 5 (10) , e0001759
Open AccessRecommendations for the analysis of leading indicators in epidemic surveillance
Leading indicator analyses, a type of time series analysis, are frequently used to assess how epidemic surveillance signals relate to one another. Strong leading indicators can drive early, and better decisions in public health systems. We conducted a narrative review of leading indicator studies and evaluated methodological limitations in their reporting and analysis, which we used to generate recommendations in retrospective surveillance analyses. Achievable recommendations are provided based on the reporting and analysis components of real-time epidemic time series analysis. We provide contextual examples from the literature of previous studies demonstrating good practice and highlighting areas for improvement. We present a checklist and workflow that emphases real-time constraints. These recommendations include causal mechanism reporting, sample coverage and bias, reporting delays and data revisions, multiple event measurement, spatio-temporal granularly, time varying relationships, smoothing, transformations, uncertainty, and predictive utility. By following these good practices, analysts can improve research on leading indicators to make analyses more directly actionable for public health decision makers. This work builds on the existing methodology literature by giving a broader framework for overall good practices.
- Open Access
- 17 September 2026
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (9)
What Different Surveillance Systems Tell Us About Winter Respiratory Illness in England: A Time‐Series Analysis Combining Participatory, Syndromic and Laboratory Datasets, 2022–2025
Background: A range of surveillance systems have been employed in England to monitor respiratory illness, including participatory, syndromic and laboratory datasets. Combined, they can provide powerful insights on the spectrum of respiratory illness across the population. We compared trends across these datasets over three successive winters. Methods: Participatory, syndromic and laboratory surveillance datasets from the UK Health Security Agency were integrated. Winter trends in influenza‐like illness (ILI), using a standardised definition, were described and compared across datasets, 2022/2023 to 2024/2025, using the cross‐correlation function (CCF). Multivariable (beta and negative binomial) regression models were used to explore the association between ILI and SARS‐CoV‐2, influenza and RSV positivity in each dataset. Results: Trends in ILI align well across participatory surveillance systems, with ILI peaking around Weeks 50–52 each season. Participatory surveillance system trends align well with syndromic healthcare use for ILI, with ILI symptoms peaking about a week before healthcare use. ILI in each dataset is driven by a different combination of respiratory viruses, with ILI in the community driven by a combination of SARS‐CoV‐2, influenza and RSV, whereas healthcare attendance was driven by influenza only. Conclusions: While each surveillance system differs in its purpose and population, trends in ILI align across datasets. Comparing a range of surveillance systems can provide increased confidence in each system. While syndromic healthcare use surveillance systems highlight the burden of severe illness, integration with participatory surveillance systems can demonstrate the wider burden across a spectrum of severity.
- 17 September 2026
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 20 (9)
Open AccessWhat Different Surveillance Systems Tell Us About Winter Respiratory Illness in England: A Time‐Series Analysis Combining Participatory, Syndromic and Laboratory Datasets, 2022–2025
Background: A range of surveillance systems have been employed in England to monitor respiratory illness, including participatory, syndromic and laboratory datasets. Combined, they can provide powerful insights on the spectrum of respiratory illness across the population. We compared trends across these datasets over three successive winters. Methods: Participatory, syndromic and laboratory surveillance datasets from the UK Health Security Agency were integrated. Winter trends in influenza‐like illness (ILI), using a standardised definition, were described and compared across datasets, 2022/2023 to 2024/2025, using the cross‐correlation function (CCF). Multivariable (beta and negative binomial) regression models were used to explore the association between ILI and SARS‐CoV‐2, influenza and RSV positivity in each dataset. Results: Trends in ILI align well across participatory surveillance systems, with ILI peaking around Weeks 50–52 each season. Participatory surveillance system trends align well with syndromic healthcare use for ILI, with ILI symptoms peaking about a week before healthcare use. ILI in each dataset is driven by a different combination of respiratory viruses, with ILI in the community driven by a combination of SARS‐CoV‐2, influenza and RSV, whereas healthcare attendance was driven by influenza only. Conclusions: While each surveillance system differs in its purpose and population, trends in ILI align across datasets. Comparing a range of surveillance systems can provide increased confidence in each system. While syndromic healthcare use surveillance systems highlight the burden of severe illness, integration with participatory surveillance systems can demonstrate the wider burden across a spectrum of severity.
- Open Access
Nocturnal cough as a syndromic surveillance signal for respiratory illness in England
We evaluated aggregated, privacy-preserving smartphone-detected nocturnal cough activity from the Sleep Cycle application as a potential syndromic surveillance signal in England. Weekly cough metrics from January 2023 to January 2026 were compared with UK Health Security Agency indicators: NHS 111 acute respiratory infection (ARI) triage calls, influenza and COVID-19 PCR positivity, and hospital admission rates for influenza, COVID-19, and respiratory syncytial virus. We evaluated total cough counts alongside two population-normalised metrics, coughs per user and coughs per hour of sleep, and assessed temporal relationships nationally and regionally using cross-correlation with prewhitening. The strongest and most consistent associations were observed for NHS 111 ARI triage calls, where population-normalised cough metrics showed raw national correlations of approximately 0.95 and retained prewhitened correlations above 0.55 at lag 0. This indicates that nocturnal cough activity closely tracks short-term variation in an established syndromic surveillance indicator, beyond shared seasonality, long-term trends, and autocorrelation. Similar near-contemporaneous patterns were observed across regions. Population-normalised cough metrics also showed epidemiologically plausible leading associations with pathogen-specific indicators: coughs per hour of sleep peaked one week before influenza PCR positivity, while both coughs per user and coughs per hour of sleep peaked one week before COVID-19 PCR positivity. Hospital-based indicators showed weaker and more heterogeneous relationships, but the normalised cough metrics still showed plausible temporal alignment with influenza and COVID-19 admissions, including contemporaneous associations with influenza admissions and short leading associations with COVID-19 admissions. In contrast, unnormalised total cough counts produced less stable and often non-interpretable lag structures, consistent with sensitivity to variation in observation volume. These findings suggest that passive, near-real-time nocturnal cough monitoring can provide a population-level signal of respiratory symptom burden, with greatest utility as a broad syndromic indicator that complements surveillance sources affected by healthcare-seeking behaviour, laboratory turnaround times, backfilling, and reporting delays.
Open AccessNocturnal cough as a syndromic surveillance signal for respiratory illness in England
We evaluated aggregated, privacy-preserving smartphone-detected nocturnal cough activity from the Sleep Cycle application as a potential syndromic surveillance signal in England. Weekly cough metrics from January 2023 to January 2026 were compared with UK Health Security Agency indicators: NHS 111 acute respiratory infection (ARI) triage calls, influenza and COVID-19 PCR positivity, and hospital admission rates for influenza, COVID-19, and respiratory syncytial virus. We evaluated total cough counts alongside two population-normalised metrics, coughs per user and coughs per hour of sleep, and assessed temporal relationships nationally and regionally using cross-correlation with prewhitening. The strongest and most consistent associations were observed for NHS 111 ARI triage calls, where population-normalised cough metrics showed raw national correlations of approximately 0.95 and retained prewhitened correlations above 0.55 at lag 0. This indicates that nocturnal cough activity closely tracks short-term variation in an established syndromic surveillance indicator, beyond shared seasonality, long-term trends, and autocorrelation. Similar near-contemporaneous patterns were observed across regions. Population-normalised cough metrics also showed epidemiologically plausible leading associations with pathogen-specific indicators: coughs per hour of sleep peaked one week before influenza PCR positivity, while both coughs per user and coughs per hour of sleep peaked one week before COVID-19 PCR positivity. Hospital-based indicators showed weaker and more heterogeneous relationships, but the normalised cough metrics still showed plausible temporal alignment with influenza and COVID-19 admissions, including contemporaneous associations with influenza admissions and short leading associations with COVID-19 admissions. In contrast, unnormalised total cough counts produced less stable and often non-interpretable lag structures, consistent with sensitivity to variation in observation volume. These findings suggest that passive, near-real-time nocturnal cough monitoring can provide a population-level signal of respiratory symptom burden, with greatest utility as a broad syndromic indicator that complements surveillance sources affected by healthcare-seeking behaviour, laboratory turnaround times, backfilling, and reporting delays.
- Open Access
Evaluation of short-term multi-target respiratory forecasts over winter 2024-25 in England using sub-ensemble contribution analyses
Background: Epidemic forecasting research often assesses ensembles and their component models using probabilistic scoring rules. Quantifying how individual models affect ensemble performance is challenging, particularly across multiple targets and spatial scales. Methods: We present Winter 2024-25 forecasts of Influenza and COVID-19 hospital admissions in England and conduct a retrospective simulation using the operational component models. Forecasts were scored using the per capita weighted interval score (pcWIS) for counts and the ranked probability score (RPS) for ordinal trend direction. We compared operational retrospective forecasts, used generalised additive models (GAMs) to estimate the expected change in score from the inclusion of a model in a sub-ensemble (an ensemble formed from a subset of available models), and used Pareto analysis to understand which sub-ensembles were Pareto-optimal across scoring rules. Results: Nationally, there was a 47% improvement in Influenza pcWIS versus sub-ensembles. However, Influenza operational ensembles were on average 22% worse than sub-ensembles, when measured by RPS. For COVID-19, operational ensembles were 43% and 280% worse on average, than retrospective sub-ensembles by pcWIS and RPS, respectively. However, COVID-19 operational ensembles were on average 2% (pcWIS) and 13% (RPS) better than individual operational models. For influenza, operational ensembles were, on average, 58% (pcWIS) and 41% (RPS) better than individual models. The sub-ensemble simulation showed individual models influenced the ensembles during different epidemic phases. The Pareto analysis demonstrated that there can be a trade-off between relative direction and absolute count score optimisation. Interpretation: Our analysis shows that UK Health Security Agency forecasts were well calibrated with observations and often had comparable performance to optimal ensembles. Our GAM and Pareto analyses inform model selection for future ensembles. Author Summary: Forecasts of winter hospital pressures in England are an important tool for senior healthcare leaders. It is common practice to produce a forecasting ensemble, i.e. combine the predictions of multiple models to create a single, more accurate prediction. Forecasting teams should strive to produce the best forecast possible; one tool for this is retrospective evaluation over a forecasting season using proper scoring rules to assess performance. Our forecasts are constructed of two components, an epidemic trend direction estimate as well as forecast of hospital admission numbers. There are two main challenges we address. The first is understanding at which epidemic phase different ensemble contributions are most effective, the second is the joint optimisation of an ensemble for both trend direction and admission numbers forecast. We apply these methods to a variety of ensembles (sub-ensembles) based on our own modelling suite, and compare the sub-ensembles to our operational forecasts from the Winter 2024/25 season.
Open AccessEvaluation of short-term multi-target respiratory forecasts over winter 2024-25 in England using sub-ensemble contribution analyses
Background: Epidemic forecasting research often assesses ensembles and their component models using probabilistic scoring rules. Quantifying how individual models affect ensemble performance is challenging, particularly across multiple targets and spatial scales. Methods: We present Winter 2024-25 forecasts of Influenza and COVID-19 hospital admissions in England and conduct a retrospective simulation using the operational component models. Forecasts were scored using the per capita weighted interval score (pcWIS) for counts and the ranked probability score (RPS) for ordinal trend direction. We compared operational retrospective forecasts, used generalised additive models (GAMs) to estimate the expected change in score from the inclusion of a model in a sub-ensemble (an ensemble formed from a subset of available models), and used Pareto analysis to understand which sub-ensembles were Pareto-optimal across scoring rules. Results: Nationally, there was a 47% improvement in Influenza pcWIS versus sub-ensembles. However, Influenza operational ensembles were on average 22% worse than sub-ensembles, when measured by RPS. For COVID-19, operational ensembles were 43% and 280% worse on average, than retrospective sub-ensembles by pcWIS and RPS, respectively. However, COVID-19 operational ensembles were on average 2% (pcWIS) and 13% (RPS) better than individual operational models. For influenza, operational ensembles were, on average, 58% (pcWIS) and 41% (RPS) better than individual models. The sub-ensemble simulation showed individual models influenced the ensembles during different epidemic phases. The Pareto analysis demonstrated that there can be a trade-off between relative direction and absolute count score optimisation. Interpretation: Our analysis shows that UK Health Security Agency forecasts were well calibrated with observations and often had comparable performance to optimal ensembles. Our GAM and Pareto analyses inform model selection for future ensembles. Author Summary: Forecasts of winter hospital pressures in England are an important tool for senior healthcare leaders. It is common practice to produce a forecasting ensemble, i.e. combine the predictions of multiple models to create a single, more accurate prediction. Forecasting teams should strive to produce the best forecast possible; one tool for this is retrospective evaluation over a forecasting season using proper scoring rules to assess performance. Our forecasts are constructed of two components, an epidemic trend direction estimate as well as forecast of hospital admission numbers. There are two main challenges we address. The first is understanding at which epidemic phase different ensemble contributions are most effective, the second is the joint optimisation of an ensemble for both trend direction and admission numbers forecast. We apply these methods to a variety of ensembles (sub-ensembles) based on our own modelling suite, and compare the sub-ensembles to our operational forecasts from the Winter 2024/25 season.
- Open Access
Sickness presenteeism due to respiratory infection in the English workforce: prevalence estimates and demographic factors from the Winter COVID-19 Infection Study (WCIS)
Background: Working while sick (presenteeism) with an infectious disease contributes to the spread of infections and is detrimental to productivity. Respiratory illnesses are a common cause of sickness in the working population and understanding the prevalence of presenteeism linked to respiratory illness is therefore important. Methods: Winter Covid Infection Study (WCIS) panel members in work aged 18-64 were surveyed in February - March 2024 and asked about presenteeism in the previous 28 days. Multilevel regression and poststratification was used to estimate the prevalence and length of presenteeism and its effect on productivity in the English workforce, as approximated using the WCIS survey sample calibrated to census proportions. Differences by demographic groups and work sector were also analysed. Results: Around one in six working adults in England worked while sick with a respiratory infection during the study period, and one in ten attended a non-home workplace. Overall, around one day per adult was spent working while sick with a respiratory infection, approximately half of which was non-home working. Respondents felt they were able to work at around three-quarters of their usual capacity while sick. Presenteeism was more common among respondents who were younger, White, worked in a hybrid pattern, lived in larger households, had Long COVID-19, or worked in teaching and education. Conclusion: Working while sick with a respiratory infection is relatively common, including among those who primarily work away from the home.
Open AccessSickness presenteeism due to respiratory infection in the English workforce: prevalence estimates and demographic factors from the Winter COVID-19 Infection Study (WCIS)
Background: Working while sick (presenteeism) with an infectious disease contributes to the spread of infections and is detrimental to productivity. Respiratory illnesses are a common cause of sickness in the working population and understanding the prevalence of presenteeism linked to respiratory illness is therefore important. Methods: Winter Covid Infection Study (WCIS) panel members in work aged 18-64 were surveyed in February - March 2024 and asked about presenteeism in the previous 28 days. Multilevel regression and poststratification was used to estimate the prevalence and length of presenteeism and its effect on productivity in the English workforce, as approximated using the WCIS survey sample calibrated to census proportions. Differences by demographic groups and work sector were also analysed. Results: Around one in six working adults in England worked while sick with a respiratory infection during the study period, and one in ten attended a non-home workplace. Overall, around one day per adult was spent working while sick with a respiratory infection, approximately half of which was non-home working. Respondents felt they were able to work at around three-quarters of their usual capacity while sick. Presenteeism was more common among respondents who were younger, White, worked in a hybrid pattern, lived in larger households, had Long COVID-19, or worked in teaching and education. Conclusion: Working while sick with a respiratory infection is relatively common, including among those who primarily work away from the home.
- Open Access
Monitoring influenza-like symptoms in the UK through participatory surveillance: insights from FluSurvey over two winter seasons (2023-24 and 2024-25)
FluSurvey is a participatory surveillance system used to monitor trends in influenza and other respiratory viruses through weekly symptom surveys among the UK population. We aimed to characterise the wider impact of influenza-like illnesses (ILI) among FluSurvey participants and assess correlations of ILI with other established influenza surveillance systems. We included data reported by FluSurvey participants over the 2023-24 and 2024-25 winter seasons. Using weekly symptoms surveys, we derived ILI episodes and estimated the proportion reporting healthcare service use, medication use, impact on daily life, absenteeism and use of tests. We applied existing data methods (omitting first report and weighting to the age-sex structure of England) and assessed cross-correlations of weekly FluSurvey ILI rates with the national surveillance of GP ILI consultations, influenza hospital admissions, and influenza PCR test positivity at time lags of up to +/-2 weeks. There were 3057 participants over two winter seasons (N 2023-24 =2540, 63% female, mean age 60 years; N 2024-25 =2273, 64% female, mean age 61 years). Of 1868 ILI episodes, only a minority contacted healthcare services (14%, most frequently visiting the GP). A large proportion of episodes reported medication use (89%), impact on daily life (75%) and missing school or work (47%). Notable differences in testing behaviour were apparent by season, with fewer reporting use of tests in 2024-25. FluSurvey ILI rates were strongly correlated with other influenza surveillance, predominantly leading GP ILI consultations (max r=0.73), coinciding with influenza hospital admissions (max r=0.88) and lagging influenza test positivity (max r=0.88). The majority of ILI reported to FluSurvey do not contact healthcare due to symptoms but experienced wider impacts on daily life. FluSurvey ILI corresponds well with other national influenza surveillance and provides broader context on community illness, supplementing the monitoring of influenza activity for public health response.
Open AccessMonitoring influenza-like symptoms in the UK through participatory surveillance: insights from FluSurvey over two winter seasons (2023-24 and 2024-25)
FluSurvey is a participatory surveillance system used to monitor trends in influenza and other respiratory viruses through weekly symptom surveys among the UK population. We aimed to characterise the wider impact of influenza-like illnesses (ILI) among FluSurvey participants and assess correlations of ILI with other established influenza surveillance systems. We included data reported by FluSurvey participants over the 2023-24 and 2024-25 winter seasons. Using weekly symptoms surveys, we derived ILI episodes and estimated the proportion reporting healthcare service use, medication use, impact on daily life, absenteeism and use of tests. We applied existing data methods (omitting first report and weighting to the age-sex structure of England) and assessed cross-correlations of weekly FluSurvey ILI rates with the national surveillance of GP ILI consultations, influenza hospital admissions, and influenza PCR test positivity at time lags of up to +/-2 weeks. There were 3057 participants over two winter seasons (N 2023-24 =2540, 63% female, mean age 60 years; N 2024-25 =2273, 64% female, mean age 61 years). Of 1868 ILI episodes, only a minority contacted healthcare services (14%, most frequently visiting the GP). A large proportion of episodes reported medication use (89%), impact on daily life (75%) and missing school or work (47%). Notable differences in testing behaviour were apparent by season, with fewer reporting use of tests in 2024-25. FluSurvey ILI rates were strongly correlated with other influenza surveillance, predominantly leading GP ILI consultations (max r=0.73), coinciding with influenza hospital admissions (max r=0.88) and lagging influenza test positivity (max r=0.88). The majority of ILI reported to FluSurvey do not contact healthcare due to symptoms but experienced wider impacts on daily life. FluSurvey ILI corresponds well with other national influenza surveillance and provides broader context on community illness, supplementing the monitoring of influenza activity for public health response.
- Open Access
- 16 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Estimating COVID-19 incidence and prevalence using lateral flow tests in England and Scotland, 2023-2024
SARS-CoV-2 continues to cause substantial morbidity and mortality, particularly in winter. During the SARS-CoV-2 pandemic, community prevalence surveys provided detailed monitoring of infection levels. The Winter Coronavirus (COVID-19) Infection Survey (WCIS), conducted in England and Scotland from the 14 th November 2023 to the 7 th March 2024, enabled the UK Health Security Agency to publish fortnightly estimates of community infection levels in England and Scotland. Unlike previous community prevalence surveys, WCIS conducted testing using Lateral Flow Device (LFD) tests, and featured a repeat testing design that enabled estimation of key epidemiological parameters. LFD tests have a substantially lower cost per unit than Polymerase Chain Reaction (PCR) tests which were used in previous SARS-CoV-2 prevalence surveys; however, they have a high false negative rate that must be accounted for to produce reliable estimates. In this manuscript, statistical methods to robustly estimate incidence and prevalence while adjusting for time-varying false negative rates are developed. This enabled timely and robust inference of the incidence and prevalence of SARS-CoV-2, stratified by age group, location and sex. Overall, the study design of WCIS overcame key limitations of earlier large-scale community prevalence studies and demonstrated the utility of LFD tests in infectious disease surveillance.
- 16 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessEstimating COVID-19 incidence and prevalence using lateral flow tests in England and Scotland, 2023-2024
SARS-CoV-2 continues to cause substantial morbidity and mortality, particularly in winter. During the SARS-CoV-2 pandemic, community prevalence surveys provided detailed monitoring of infection levels. The Winter Coronavirus (COVID-19) Infection Survey (WCIS), conducted in England and Scotland from the 14 th November 2023 to the 7 th March 2024, enabled the UK Health Security Agency to publish fortnightly estimates of community infection levels in England and Scotland. Unlike previous community prevalence surveys, WCIS conducted testing using Lateral Flow Device (LFD) tests, and featured a repeat testing design that enabled estimation of key epidemiological parameters. LFD tests have a substantially lower cost per unit than Polymerase Chain Reaction (PCR) tests which were used in previous SARS-CoV-2 prevalence surveys; however, they have a high false negative rate that must be accounted for to produce reliable estimates. In this manuscript, statistical methods to robustly estimate incidence and prevalence while adjusting for time-varying false negative rates are developed. This enabled timely and robust inference of the incidence and prevalence of SARS-CoV-2, stratified by age group, location and sex. Overall, the study design of WCIS overcame key limitations of earlier large-scale community prevalence studies and demonstrated the utility of LFD tests in infectious disease surveillance.
- Open Access
Case Fatality Risk of Norovirus in England During a Period of Strain Replacement, 2022/23 - 2024/25 Seasons
Background Norovirus causes substantial burden to healthcare systems. England experienced high activity in recent seasons alongside a shift in the dominant genotype from GII.4 to GII.17. It remains unclear whether this increased burden reflects changes in severity or other transmission mechanisms associated with the strain replacement. Methods Individual-level testing and mortality data in England from 2022/23-2024/25 seasons were linked from national surveillance systems. Piece-wise exponential additive mixed models estimated all-cause case-fatality risk (CFR) for death within 28 days of a positive test, adjusting for age, location, primary or secondary care case identification and temporal effects. Additional analysis tested the effect of the death linkage threshold. Results CFR did not differ significantly between GII.4 and GII.17, but increased markedly with age and was substantially higher for cases detected in secondary versus primary care. At the 2024/25 season peak, the CFR for the average cohort case (age 75) was 8.01% (95% CI: 6.88-9.33%) for cases identified in secondary care compared with 1.18% (95% CI: 0.61-2.25%) for primary care, likely driven by different case mixes and unmeasured confounding between patients managed in these settings. Interpretation We found no evidence that the newly dominant GII.17 genotype had higher CFR than GII.4 among test-positive cases. The increased burden is therefore more consistent with changes in transmissibility, population immunity, or testing dynamics than increased genotype-specific severity. Norovirus remains a major public health threat, and understanding genotype switching supports enhanced surveillance, expanded genotyping, routine clinical data linkage and advanced modelling to inform control strategies.
Open AccessCase Fatality Risk of Norovirus in England During a Period of Strain Replacement, 2022/23 - 2024/25 Seasons
Background Norovirus causes substantial burden to healthcare systems. England experienced high activity in recent seasons alongside a shift in the dominant genotype from GII.4 to GII.17. It remains unclear whether this increased burden reflects changes in severity or other transmission mechanisms associated with the strain replacement. Methods Individual-level testing and mortality data in England from 2022/23-2024/25 seasons were linked from national surveillance systems. Piece-wise exponential additive mixed models estimated all-cause case-fatality risk (CFR) for death within 28 days of a positive test, adjusting for age, location, primary or secondary care case identification and temporal effects. Additional analysis tested the effect of the death linkage threshold. Results CFR did not differ significantly between GII.4 and GII.17, but increased markedly with age and was substantially higher for cases detected in secondary versus primary care. At the 2024/25 season peak, the CFR for the average cohort case (age 75) was 8.01% (95% CI: 6.88-9.33%) for cases identified in secondary care compared with 1.18% (95% CI: 0.61-2.25%) for primary care, likely driven by different case mixes and unmeasured confounding between patients managed in these settings. Interpretation We found no evidence that the newly dominant GII.17 genotype had higher CFR than GII.4 among test-positive cases. The increased burden is therefore more consistent with changes in transmissibility, population immunity, or testing dynamics than increased genotype-specific severity. Norovirus remains a major public health threat, and understanding genotype switching supports enhanced surveillance, expanded genotyping, routine clinical data linkage and advanced modelling to inform control strategies.
- Open Access
- 28 November 2025
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 153, 1-28
Evaluating Google Trends as a proxy for symptom incidence: insights from the winter COVID-19 infection study in England 2023/24
Google Trends is used in research and surveillance as a proxy for community infection incidence. Signals are difficult to validate, as most surveillance biases towards severe outcomes and certain demographics. Using Winter COVID-19 Infection Study (WCIS) data in England, symptom prevalence is estimated via generalized additive model with multilevel-regression and poststratification. Symptom duration was estimated using interval censored time delay modelling, converting prevalence to incidence. Google Trends and WCIS incidence and growth rates were compared using cross-correlation. Google Trends and WCIS agreement varied by symptom and age group. The national maximum growth rate cross-correlation for sore throat was 0.81, with 90% prediction intervals of [0.69, 0.90]. Google Trends growth rates generally lagged the WCIS growth rates across symptoms (cough: −5.0 days [−8.0, 0.0], fever: −3.0 days [−6.0, 1.0], loss of smell: −9.0 days [−13, −3.0], shortness of breath: −12 days [−16, −5.0], and sore throat: −4.0 days [−5.0, −2.0]). This work shows Google Trends and community symptom incidence can align, although substantial variation between symptoms and age groups exists, underscoring utility in predicting other surveillance indicators.
- 28 November 2025
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 153, 1-28
Open AccessEvaluating Google Trends as a proxy for symptom incidence: insights from the winter COVID-19 infection study in England 2023/24
Google Trends is used in research and surveillance as a proxy for community infection incidence. Signals are difficult to validate, as most surveillance biases towards severe outcomes and certain demographics. Using Winter COVID-19 Infection Study (WCIS) data in England, symptom prevalence is estimated via generalized additive model with multilevel-regression and poststratification. Symptom duration was estimated using interval censored time delay modelling, converting prevalence to incidence. Google Trends and WCIS incidence and growth rates were compared using cross-correlation. Google Trends and WCIS agreement varied by symptom and age group. The national maximum growth rate cross-correlation for sore throat was 0.81, with 90% prediction intervals of [0.69, 0.90]. Google Trends growth rates generally lagged the WCIS growth rates across symptoms (cough: −5.0 days [−8.0, 0.0], fever: −3.0 days [−6.0, 1.0], loss of smell: −9.0 days [−13, −3.0], shortness of breath: −12 days [−16, −5.0], and sore throat: −4.0 days [−5.0, −2.0]). This work shows Google Trends and community symptom incidence can align, although substantial variation between symptoms and age groups exists, underscoring utility in predicting other surveillance indicators.
- Open Access
- 28 April 2025
- Published by Elsevier in Journal of Infection
- Vol. 90 (6) , 106485
SARS-CoV-2 test sensitivity and duration of positivity in the UK during the 2023/2024 Winter: A prospective cohort study based on self-reported data
- 28 April 2025
- Published by Elsevier in Journal of Infection
- Vol. 90 (6) , 106485
Open AccessSARS-CoV-2 test sensitivity and duration of positivity in the UK during the 2023/2024 Winter: A prospective cohort study based on self-reported data